A Novel Poly-Naphthol Compound ST104P Suppresses Angiogenesis by Attenuating Matrix Metalloproteinase-2 Expression in Endothelial Cells

• Main Authors: Yi-Ling Ma, Shih-Wei Lin, Hua-Chang Fang, Kang-Ju Chou, Youn-Shen Bee, Tian-Huei Chu, Ming-Chi Chang, Wen-Tsan Weng, Chang-Yi Wu, Chung-Lung Cho, Ming-Hong Tai
• Format: Article
• Language: English
• Published: MDPI AG 2014-09-01
• Series: International Journal of Molecular Sciences
• Subjects: ST104P; angiogenesis; Lewis lung carcinoma; matrix metalloproteinase-2 (MMP-2)
• Online Access: http://www.mdpi.com/1422-0067/15/9/16611

Angiogenesis, the process of neovascularization, plays an important role in physiological and pathological conditions. ST104P is a soluble polysulfated-cyclo-tetrachromotropylene compound with anti-viral and anti-thrombotic activities. However, the functions of ST104P in angiogenesis have never been explored. In this study, we investigated the effects of ST104P in angiogenesis in vitro and in vivo. Application of ST104P potently suppressed the microvessels sprouting in aortic rings ex vivo. Furthermore, ST104P treatment significantly disrupted the vessels’ development in transgenic zebrafish in vivo. Above all, repeated administration of ST104P resulted in delayed tumor growth and prolonged the life span of mice bearing Lewis lung carcinoma. Mechanistic studies revealed that ST104P potently inhibited the migration, tube formation and wound closure of human umbilical endothelial cells (HUVECs). Moreover, ST104P treatment inhibited the secretion and expression of matrix metalloproteinase-2 (MMP-2) in a dose-dependent manner. Together, these results suggest that ST104P is a potent angiogenesis inhibitor and may hold potential for treatment of diseases due to excessive angiogenesis including cancer.